🚢 The addition of the CDK4/6 inhibitor #palbociclib to first-line maintenance therapy after induction #chemotherapy is charting a new territory of treatment for double- and triple-postitive #metastatic #breastcancer. 🚢 Read more: https://t.co/Ns41TbXDzf https://t.co/74gajcoJAO